sábado, 14 de noviembre de 2026
BuscarExplore
es.VIA.NEWS
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 9, 2026

Singapore Cold Chain Logistics Market Set to Surpass Valuation of US$ 3,942.30 Million By 2035 | Astute Analytica

View original at globenewswire.com
“SATS Ltd's Food Solutions division saw revenue grow by $33.8 million in the final quarter of FY2025, largely driven by the recovery of chilled meal catering for aviation and institutional clients.”
Verbatim excerpt from the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The regulated electricity tariff for Jan-Mar 2026 is set at 26.71 cents per kWh

    80% confidence

  • Red Lion 2's automation is projected to increase warehouse productivity by 100% compared to manual processes

    80% confidence

  • The Singapore cold chain logistics market is valued at approximately USD 2,010 million, with a projected trajectory to breach USD 3,942.30 million by 2035, growing at a CAGR of 7.40% during the forecast period 2026–2035

    80% confidence

  • Authorities recorded a foodborne illness rate of 22.8 cases per 100,000 population in 2024

    80% confidence

  • Vegetable farm productivity hit 231.4 tons per hectare in 2025

    80% confidence

  • Smart refrigeration systems in the Singapore cold chain logistics market are now delivering energy savings of up to 30%

    80% confidence

  • The nation now sources food from 187 countries, a diversification that requires sophisticated chilled supply chains

    80% confidence

  • Integrated IT platforms in new facilities reduce customer lead times by 40%

    80% confidence
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
Nuestra lectura de los datos ›
Señales que seguimos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patrones que observamos ›
Donde las fuentes discrepan
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,995
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,995 hechos verificados con la fuente5,577 documentos fuente archivados
Consulta estos datos → isubstrate.com
Singapore Cold Chain Logistics Market Set to Surpass Valuation of US$ 3,942.30 Million By 2035 | Astute Analytica — Source | Via News | es.VIA.NEWS